Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus and Everolimus in Kidney Transplant Recipients
NCT02954198Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus and everolimus in kidney transplantation, sponsored by Medical University of South Carolina. Started Dec 2016; status: completed.
02
Drugs
tacrolimuseverolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02954198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954198.